BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30185620)

  • 1. Dissecting MMP P
    Tokmina-Roszyk M; Fields GB
    J Biol Chem; 2018 Oct; 293(43):16661-16676. PubMed ID: 30185620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.
    Stawikowski MJ; Stawikowska R; Fields GB
    Biochemistry; 2015 May; 54(19):3110-21. PubMed ID: 25897652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Visse R; Nagase H; Fields GB
    J Biol Chem; 2006 Dec; 281(50):38302-13. PubMed ID: 17065155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Substrate Specificity of Matrix Metalloproteases using Fluorogenic Peptide Substrates.
    Stawikowski MJ; Knapinska AM; Fields GB
    Methods Mol Biol; 2017; 1579():137-183. PubMed ID: 28299736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of collagen charge clusters in the modulation of matrix metalloproteinase activity.
    Lauer JL; Bhowmick M; Tokmina-Roszyk D; Lin Y; Van Doren SR; Fields GB
    J Biol Chem; 2014 Jan; 289(4):1981-92. PubMed ID: 24297171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
    Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
    Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
    J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
    Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
    Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
    Lauer-Fields JL; Tuzinski KA; Shimokawa Ki; Nagase H; Fields GB
    J Biol Chem; 2000 May; 275(18):13282-90. PubMed ID: 10788434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synergy between the catalytic and structural Zn(II) ions and the enzyme and substrate dynamics underlies the structure-function relationships of matrix metalloproteinase collagenolysis.
    Varghese A; Chaturvedi SS; Fields GB; Karabencheva-Christova TG
    J Biol Inorg Chem; 2021 Aug; 26(5):583-597. PubMed ID: 34228191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
    Lauer-Fields JL; Kele P; Sui G; Nagase H; Leblanc RM; Fields GB
    Anal Biochem; 2003 Oct; 321(1):105-15. PubMed ID: 12963061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
    Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
    J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
    Fields GB
    Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage.
    Howes JM; Bihan D; Slatter DA; Hamaia SW; Packman LC; Knauper V; Visse R; Farndale RW
    J Biol Chem; 2014 Aug; 289(35):24091-101. PubMed ID: 25008319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for the Construction of Collagen-Based Triple-Helical Peptides Designed as Matrix Metalloproteinase Inhibitors.
    Fields GB
    Methods Mol Biol; 2019; 1944():229-252. PubMed ID: 30840247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and application of Fmoc-Lys(5-Fam) building blocks.
    Tokmina-Roszyk M; Tokmina-Roszyk D; Fields GB
    Biopolymers; 2013 Jul; 100(4):347-55. PubMed ID: 23444261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays of matrix metalloproteinases (MMPs) activities: a review.
    Lombard C; Saulnier J; Wallach J
    Biochimie; 2005; 87(3-4):265-72. PubMed ID: 15781313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.